Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk (Q28554193)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

title

Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Ju-Chi Liu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

Yi-Ping Hsu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

English

0 references

publication date

15 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

e0162588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

23 March 2020

copyright license

start time

15 September 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Statin-Based Palliative Therapy for Hepatocellular Carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Epidemiology, impact and preventive care of chronic kidney disease in Taiwan

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Excerpts from the US Renal Data System 2009 Annual Data Report

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Meta-analysis: the effect of statins on albuminuria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Statins for improving renal outcomes: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Prognostic significance of arterial stiffness measurements in end-stage renal disease patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

The clinical epidemiology of cardiac disease in chronic renal failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

29 September 2017

Lipids and the kidney

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Cholesterol and the risk of renal dysfunction in apparently healthy men.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Effects of hypertension and dyslipidemia on the decline in renal function

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5025231

A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and hemodialysis in Taiwan.

3 June 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Consent for research with biological samples: one-time general consent versus a gift model

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Beneficial effects of fluvastatin on progressive renal allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

HMG-CoA reductase inhibitors and renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Bias toward the null hypothesis in model-free linkage analysis is highly dependent on the test statistic used

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0162588

Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin

21 January 2018

1 reference

12 December 2020

Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats

1 reference

12 December 2020

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes

1 reference

12 December 2020

Atrial natriuretic factor in the acute nephritic and nephrotic syndromes

1 reference

12 December 2020

Statins for prevention of hepatocellular cancer: one step closer?

1 reference

12 December 2020

Cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Managing dyslipidemia in chronic kidney disease

1 reference

12 December 2020

Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin

1 reference

12 December 2020

Combined antihypertensive and lipid-lowering therapy in experimental glomerulonephritis

1 reference

12 December 2020

Does hyperlipidemia injure the kidney?

1 reference

12 December 2020

Short-term treatment with captopril in hypertension due to acute glomerulonephritis

1 reference

12 December 2020

Does evidence support renin-angiotensin system blockade for slowing nephropathy progression in elderly persons?

1 reference

12 December 2020

The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0162588

Identifiers

DOI

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

0 references

release_txnbzlyby5hinhujp3ulmsan6e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/txnbzlyby5hinhujp3ulmsan6e

24 November 2022

mapped directly with Wikidata item

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27632175 AND SRC:MED&resulttype=core&format=json

23 March 2020

PubMed publication ID

27632175

2 references